- Breast
- Lung
- Hematologic Oncology
- Gastrointestinal
- Genitourinary
- General Oncology
- Sarcoma
- Skin
- Head & Neck
- Event
Playback speed
10 seconds
2019 SOHO Update on AML: FLT3 and IDH1/2 Inhibitors, Venetoclax, Antibodies, CAR-T CPIs, CD70 Ab / CD47 Ab, and APR 246 for p53-Mutated MDS/AML
194 views
December 9, 2019
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology